Ból piersi
Epidemiologia

Mastalgia, obejmująca ból piersi, dotyka do 70% kobiet w ciągu życia, z dominacją bólu cyklicznego u kobiet w wieku 20-30 lat oraz bólu niecyklicznego u kobiet 30-40-letnich. Epidemiologicznie częstość występowania zmniejsza się z wiekiem, a także po menopauzie i wczesnej ciąży. Ból piersi, choć najczęściej łagodny, u około 11% pacjentek ma umiarkowane do ciężkiego nasilenie, wpływając negatywnie na jakość życia, aktywność seksualną (40%), fizyczną (30%) oraz społeczną (10%). Mastalgia cykliczna stanowi około 66% przypadków, a ból niecykliczny, szczególnie u kobiet po menopauzie, wymaga diagnostyki obrazowej ze względu na potencjalne ryzyko nowotworu. Ryzyko raka piersi u pacjentek z izolowanym bólem piersi po prawidłowym badaniu klinicznym i mammografii wynosi około 0,5%, co potwierdza niskie powiązanie mastalgii z nowotworem. Diagnostyka powinna opierać się na szczegółowym wywiadzie, badaniu fizykalnym oraz, w razie potrzeby, obrazowaniu piersi zgodnie z kryteriami ACR, zwłaszcza u pacjentek z bólem niecyklicznym i w starszym wieku.

Epidemiologia bólu piersi

Ból piersi (mastalgia) stanowi jeden z najczęstszych objawów dotyczących gruczołu piersiowego, dotykający znaczącą część populacji kobiet. Według danych epidemiologicznych, aż 70% kobiet doświadcza bólu piersi w ciągu swojego życia, a szczyt zachorowalności przypada na wiek 20-30 lat w przypadku bólu cyklicznego oraz 30-40 lat dla bólu niecyklicznego1234. Częstość występowania mastalgii zmniejsza się wraz z wiekiem oraz wczesną ciążą, a także rzadziej występuje u kobiet po menopauzie5.

Około 30% kobiet z bólem piersi szuka pomocy medycznej, a u 20% z nich objawy mają charakter ciężki6. Według danych z Holandii i USA, około 3% konsultacji kobiet u lekarzy pierwszego kontaktu dotyczy objawów związanych z piersiami, głównie u kobiet w wieku 30-50 lat7. Mastalgia stanowi najczęstszy objaw, z którym pacjentki zgłaszają się do poradni chorób piersi, będąc przyczyną około połowy nowych wizyt8.

Rozpowszechnienie bólu piersi na świecie

Występowanie bólu piersi wykazuje znaczące różnice geograficzne i etniczne. W Wielkiej Brytanii około 60% kobiet zgłasza ból piersi, podczas gdy wśród kobiet pochodzenia azjatyckiego częstość ta wynosi zaledwie 5%9. W Bangladeszu wskaźnik rozpowszechnienia mastalgii określono na 35,5%, będąc drugim najczęstszym powikłaniem związanym z piersiami, z ogólną częstością występowania 24,22%1011.

Badania przeprowadzone w Iranie wykazały, że wśród 845 uczestniczek, 33% (279) doświadczyło mastalgii w ciągu ostatnich trzech miesięcy. Spośród kobiet z mastalgią, 81% (226) miało ból cykliczny, a 19% (53) ból niecykliczny12. Wyniki tego badania pokazały, że rozpowszechnienie mastalgii wśród irańskich kobiet jest niższe niż wskazują badania zachodnie i ma mniejszy wpływ na ich codzienne, seksualne i związane ze snem aktywności13.

Czynniki wpływające na występowanie bólu piersi

Badania wykazały związek między zwiększoną częstością występowania bólu piersi a niskim poziomem aktywności fizycznej, chociaż nasilenie bólu nie różniło się między grupami o różnym poziomie aktywności14. Wyższe wskaźniki występowania obserwuje się u osób starszych, kobiet z większymi piersiami oraz tych, które są mniej sprawne i aktywne15.

Warto zauważyć, że częstość występowania łagodnych zaburzeń piersi zaczyna wzrastać w drugiej dekadzie życia i osiąga szczyt w czwartej i piątej dekadzie, w przeciwieństwie do chorób złośliwych, których częstość występowania nadal rośnie po menopauzie16.

Nasilenie bólu i wpływ na jakość życia

Chociaż większość kobiet opisuje ból piersi jako łagodny, około 11% zgłasza ból o nasileniu umiarkowanym do ciężkiego171819. Nasilenie bólu związanego z cykliczną mastalgią może być znaczne, porównywalne z przewlekłym bólem nowotworowym i nieco mniejsze niż w przypadku reumatoidalnego zapalenia stawów20.

Ból piersi ma istotny wpływ na jakość życia kobiet. Do 40% pacjentek zgłasza zakłócenia aktywności seksualnej, 30% ograniczenie aktywności fizycznej, a 10% wpływ na pracę i aktywności społeczne21. W irańskim badaniu wpływ mastalgii na codzienne i seksualne aktywności oraz zachowania związane ze snem zgłaszało odpowiednio 9,31% (26), 12,66% (29) i 13,97% (36) kobiet22.

Wiele pacjentek z bólem piersi zgłasza negatywny wpływ na jakość życia23. Lekarze często uznają ból piersi za objaw błahy, ale dla wielu kobiet mastalgia powoduje znaczny dyskomfort i niepokój24. Ból kompromituje jakość życia pacjentek z rakiem piersi, szczególnie tych z zaawansowanymi stadiami choroby25.

Ból piersi a obawy dotyczące raka

Dwie najczęstsze obawy pacjentek zgłaszających się z mastalgią to obecność silnego bólu wpływającego na jakość życia oraz lęk przed rakiem piersi26. Pomimo braku dowodów sugerujących, że mastalgia sama w sobie jest związana z rakiem piersi, nadal powszechnie kieruje się pacjentki do specjalistycznych ośrodków leczenia chorób piersi – w jednym z badań stanowiła ona 41% skierowań27.

Niestety, ból piersi może znacząco wpływać na jakość życia i wywoływać strach przed chorobą nowotworową, często skutkując skierowaniem na diagnostykę obrazową28. Chociaż badania potwierdzają pogląd, że nie istnieją silne związki między bólem piersi a rakiem piersi, dyskomfort i strach przed rakiem piersi wywołane bólem są trwałe29.

Mastalgia a ryzyko wystąpienia raka piersi

Wyniki badań epidemiologicznych jednoznacznie wskazują, że sam ból piersi rzadko wiąże się z rakiem. Częstość występowania raka wśród kobiet zgłaszających się z bólem piersi szacuje się na mniej niż 10%, przy czym osoby z guzkami piersi mają wyższe ryzyko złośliwości niż te z bólem piersi30.

Ryzyko złośliwości u pacjentek z bólem piersi po prawidłowym badaniu klinicznym piersi i wynikach mammografii wynosi około 0,5%3132. W przeglądzie wielu badań częstość wykrywania złośliwości u pacjentek zgłaszających się z izolowanym, klinicznie istotnym bólem piersi wynosiła 0,5%, a niektóre badania wykazały, że częstość wykrywania złośliwości u osób z bólem piersi była niższa niż w populacji ogólnej poddawanej badaniom przesiewowym33.

Dane z badań klinicznych

W badaniu przeprowadzonym na 10 830 kobietach, 1972 (18%) skierowano z powodu bólu piersi. Spośród tych pacjentek, częstość występowania raka piersi wynosiła 0,4%, w porównaniu z 5% w każdej z trzech pozostałych grup klinicznych (pacjentki z guzkami, objawami brodawkowymi i „innymi” objawami)3435.

W innym badaniu częstość występowania raka u pacjentek z mastalgią (n = 646) wynosiła 0,8%36. Porównując pacjentki z objawem mastalgii i rutynową kontrolą, nie stwierdzono różnicy w częstości występowania raka piersi37.

Badania radiograficzne wykazały jedynie 0-1,2% częstość występowania raka piersi w związku z bólem piersi38. Według jednego z badań, ujemna wartość predykcyjna i czułość w wykrywaniu złośliwości w izolowanym bólu za pomocą zarówno mammografii, jak i USG wynosiła 100%39.

Ból cykliczny vs. niecykliczny

Ból cykliczny stanowi około dwóch trzecich wszystkich przypadków bólu piersi i jest najczęstszy u kobiet w wieku 20-30 lat4041. Niecykliczny ból piersi nie ma związku czasowego z miesiączką i może być ogniskowy lub rozlany42.

Niecykliczny/ogniskowy ból piersi powinien skłonić do diagnostyki obrazowej ze względu na jego rzadkie, ale sporadyczne powiązanie z chorobą nowotworową43. Ponieważ wszystkie pacjentki z rakiem w grupie z mastalgią miały ból niecykliczny, a większość z nich była w okresie pomenopauzalnym, należy stwierdzić, że pacjentki o tych cechach powinny być dokładniej zbadane44.

Nadzór i monitorowanie bólu piersi

Diagnostyka obrazowa nie jest potrzebna u pacjentek z cykliczną mastalgią, jeśli rutynowa mammografia przesiewowa jest aktualna, a wyniki badania fizykalnego są prawidłowe45. Jednak obrazowanie piersi w przypadku jakiegokolwiek rodzaju bólu piersi może pomóc określić, czy istnieje podstawowa i uleczalna przyczyna46.

Zgodnie z kryteriami odpowiedniości ACR dla bólu piersi, ocena obrazowa jest zwykle odpowiednia w przypadku klinicznie istotnego bólu, aby wykluczyć mało prawdopodobny nowotwór jako przyczynę bólu, określić możliwą do leczenia łagodną etiologię lub uspokoić pacjenta, że nie występują nieprawidłowości w obrazowaniu47.

Ocena i monitorowanie pacjentek

Ocena bólu piersi rozpoczyna się od dokładnego wywiadu i starannego badania fizykalnego. Szczególną uwagę należy zwrócić na rodzaj bólu, jego lokalizację i związek z cyklem miesiączkowym48. U zdecydowanej większości kobiet z bólem piersi, badanie fizykalne i mammografia nie wykazują żadnych dowodów patologii piersi49.

Prospektywny dziennik bólu piersi może być pomocny, jeśli lekarz próbuje odróżnić mastalgię cykliczną od niecyklicznej50. W przypadku bólu niecyklicznego, szczególnie u starszych kobiet, należy przeprowadzić ocenę, ponieważ istnieje niewielki związek ze złośliwością51.

Koszty i efektywność nadzoru

Kierowanie kobiet z bólem piersi do diagnostycznej kliniki raka piersi jest związane z brakiem wymiernych korzyści zdrowotnych, ale ze zwiększonymi kosztami i nie jest efektywnym wykorzystaniem zasobów opieki zdrowotnej52. Całkowity koszt wizyt w klinice piersi dla 1972 kobiet skierowanych wyłącznie z powodu bólu wyniósł 531 817 £, a więc koszt na jeden wykryty przypadek raka piersi w tej grupie (n = 8) wyniósł 66 477 £53.

Największy wpływ na ICER (przyrostowy współczynnik efektywności kosztów) wystąpił, gdy wykluczono utratę QALY (lat życia skorygowanych o jakość) z powodu niepokoju związanego ze skierowaniem; uspokojenie w podstawowej opiece zdrowotnej nie dominowało już, ale ICER (45 528 £/QALY) był nadal większy niż typowe progi opłacalności stosowane przy podejmowaniu decyzji w brytyjskiej NHS54.

Ból piersi a czynniki psychologiczne

Badania wskazują na istotną rolę czynników psychologicznych w doświadczaniu bólu piersi. W jednym z badań wykazano znaczącą dodatnią korelację między poczuciem samotności a bólem w drugim i szóstym dniu pooperacyjnym, a także bólem po sześciu miesiącach po operacji piersi55.

Wyniki pokazały, że zwiększenie o jedną jednostkę bólu przedoperacyjnego wiązało się ze wzrostem o 0,22 bólu w drugim dniu (wartość p=0,044) i wzrostem o 0,2 bólu w szóstym miesiącu (wartość p=0,026). Wzrost w skali samotności (ULS-8) był istotnie związany z wyższymi wartościami bólu w drugim dniu (b=0,13, wartość p=0,011), w siódmym dniu (b=0,09, wartość p=0,019) i w szóstym miesiącu (b=0,014, wartość p=0,001)56.

Ból pooperacyjny po operacji piersi

Stwierdzono, że sześć miesięcy po operacji piersi 47,6% pacjentek nadal doświadczało klinicznie znaczącego bólu, z czego 8,9% miało silny ból57. Częstość występowania przewlekłego bólu pooperacyjnego w chirurgii piersi waha się od 25 do 60%, w zależności od populacji badanej i różnic w definiowaniu uporczywego bólu58.

Opublikowana częstość występowania mastektomii/” title=”zespół bólu po mastektomii” class=”to-tag” data-termid=”122223″>zespołu bólu po mastektomii (PMPS) waha się między 11-57% według różnych źródeł. Częstość zmniejsza się do 5-10%, gdy ból jest oceniany jako ciężki. Do 65% pacjentów prezentuje cechy neuropatyczne59.

Nie znaleziono związku między pojawieniem się przewlekłego bólu a żadną z badanych zmiennych6061. Konieczne jest przeprowadzenie nowych badań prospektywnych, które będą obejmować uzgodnioną definicję PMPS w celu wyjaśnienia możliwych czynników ryzyka wpływających na częstość występowania, natężenie lub wpływ na jakość życia pacjentów62.

Wpływ czynników psychologicznych na leczenie

Uspokojenie jest leczeniem pierwszego rzutu w przypadku mastalgii i może być skuteczne u nawet 85% kobiet, przy czym większy sukces osiąga się u pacjentek z łagodnymi lub umiarkowanymi przypadkami niż u tych z ciężką mastalgią63.

W przypadkach, gdy obrazowanie jest prawidłowe, niektóre pacjentki pozostają zaniepokojone możliwością wystąpienia choroby nowotworowej, co prowadzi do powtarzających się badań klinicznych i obrazowych64. Dlatego też zapewnienie pacjentki podczas konsultacji diagnostycznej jest ważne, aby pomóc w edukacji i zminimalizować niepokój65.

Podsumowanie danych epidemiologicznych

Ból piersi jest niezwykle powszechnym objawem, dotykającym do 70-80% kobiet w ciągu życia66. W społeczeństwach zachodnich mastalgia, która odnosi się do bólu piersi bez żadnej podstawowej patologii, jest częstą dolegliwością, która może dotykać do 70% kobiet w ciągu ich życia67.

Badania pokazują, że ból cykliczny ustępuje w ciągu trzech miesięcy od wystąpienia w około 3 na 10 przypadków68. W ponad 75% przypadków ból ustępuje bez żadnego specyficznego leczenia69.

Kobiety z bólem piersi powinny być uspokajane, że nie są narażone na większe ryzyko raka piersi niż kobiety bez objawów70. Częstość występowania przedinwazyjnych lub inwazyjnych nowotworów złośliwych u kobiet skierowanych wyłącznie z bólem piersi wynosiła 0,4%, w porównaniu z 5,4% częstością występowania u kobiet skierowanych z guzkiem piersi71.

Wyniki badań sugerują, że ból piersi jest istotnym problemem w populacji ogólnej, a jednak jest to pierwsze badanie, które to zbadało72. Stąd wniosek, że stan ten wymaga zwiększonego badania, świadomości i leczenia73.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 18.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Mastalgia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK562195/
    Mastalgia, or breast pain, affects up to 70% of women and is a frequent concern in primary care, though it is rarely linked to breast cancer. […] Experts estimate that 70% of women in the United States experience breast pain during their lifetime, of which around 30% seek medical attention. Of those patients who present to a clinician for evaluation of mastalgia, 20% have severe symptoms. […] The peak age of incidence for cyclic mastalgia is 20 to 30 years of life. The incidence decreases with increasing age and early pregnancy and is less commonly found in postmenopausal women. Noncyclic mastalgia has a higher prevalence in women aged between 30 and 40. […] Many female patients with breast pain report a negative impact on their life quality. Up to 40% of women will describe interference with sexual activity, interference with physical activity by 30%, and impact on work and social activities in 10% of patients.
  • #2 Understanding Breast Pain – Montclair Breast Center
    https://montclairbreastcenter.com/understanding-breast-pain/
    70% of women feel breast pain at some point in their life. […] 75% of breast pain reported is related to a woman’s menstrual cycle, with more pain generally felt before a period. […] Non-cyclical breast pain is less common and can last for years and then disappear. […] For more information about breast pain causes and treatments, contact us!
  • #3 Breast pain – Wikipedia
    https://en.wikipedia.org/wiki/Breast_pain
    Breast pain is one of the most common breast symptoms, along with breast masses and nipple discharge. […] About 70% of women have breast pain at some point in time. […] In more than 75% of people the pain resolves without any specific treatment. […] Diagnosis involves breast examination, with medical imaging if only a specific part of the breast hurts. […] Diagnostic testing can be useful. Typical tests used are mammogram, excisional biopsy for solid lumps, fine-needle aspiration and biopsy, pregnancy test, ultrasonography, and magnetic resonance imaging (MRI). […] Ruling out the other possible causes of the pain is one way to differentiate the source of the pain.
  • #4 Breast Pain (Causes, Symptoms and Treatment)
    https://patient.info/doctor/breast-pain-pro
    Breast pain is one of the most common breast symptoms experienced by women, and management requires careful assessment and diagnosis. […] Up to 70% of women will experience breast pain in their lifetime. […] According to data from the Netherlands and the USA, around 3% of women’s consultations with their GPs are about breast symptoms, usually in women aged 30-50 years. […] In patients attending for breast problems in specialist clinics and general practice, breast pain is the most common symptom. It is the presenting symptom in about half of new patients in breast clinics. […] In two thirds of cases, the pain is cyclical and is worst a week premenstrually and peri-menstrually. Cyclical mastalgia manifests at around 30 years of age; the onset of noncyclical mastalgia is notably later, at a mean age of 41.
  • #5 Mastalgia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK562195/
    Mastalgia, or breast pain, affects up to 70% of women and is a frequent concern in primary care, though it is rarely linked to breast cancer. […] Experts estimate that 70% of women in the United States experience breast pain during their lifetime, of which around 30% seek medical attention. Of those patients who present to a clinician for evaluation of mastalgia, 20% have severe symptoms. […] The peak age of incidence for cyclic mastalgia is 20 to 30 years of life. The incidence decreases with increasing age and early pregnancy and is less commonly found in postmenopausal women. Noncyclic mastalgia has a higher prevalence in women aged between 30 and 40. […] Many female patients with breast pain report a negative impact on their life quality. Up to 40% of women will describe interference with sexual activity, interference with physical activity by 30%, and impact on work and social activities in 10% of patients.
  • #6 Mastalgia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK562195/
    Mastalgia, or breast pain, affects up to 70% of women and is a frequent concern in primary care, though it is rarely linked to breast cancer. […] Experts estimate that 70% of women in the United States experience breast pain during their lifetime, of which around 30% seek medical attention. Of those patients who present to a clinician for evaluation of mastalgia, 20% have severe symptoms. […] The peak age of incidence for cyclic mastalgia is 20 to 30 years of life. The incidence decreases with increasing age and early pregnancy and is less commonly found in postmenopausal women. Noncyclic mastalgia has a higher prevalence in women aged between 30 and 40. […] Many female patients with breast pain report a negative impact on their life quality. Up to 40% of women will describe interference with sexual activity, interference with physical activity by 30%, and impact on work and social activities in 10% of patients.
  • #7 Breast Pain (Causes, Symptoms and Treatment)
    https://patient.info/doctor/breast-pain-pro
    Breast pain is one of the most common breast symptoms experienced by women, and management requires careful assessment and diagnosis. […] Up to 70% of women will experience breast pain in their lifetime. […] According to data from the Netherlands and the USA, around 3% of women’s consultations with their GPs are about breast symptoms, usually in women aged 30-50 years. […] In patients attending for breast problems in specialist clinics and general practice, breast pain is the most common symptom. It is the presenting symptom in about half of new patients in breast clinics. […] In two thirds of cases, the pain is cyclical and is worst a week premenstrually and peri-menstrually. Cyclical mastalgia manifests at around 30 years of age; the onset of noncyclical mastalgia is notably later, at a mean age of 41.
  • #9 Mastalgia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK562195/
    Mastalgia is uncommon in men but has been documented in male patients with conditions, eg, gynecomastia and hormonal dysfunction. […] The worldwide prevalence of breast pain varies depending on the population being studied. A study was conducted on women from the United Kingdom using a survey to correlate physical activity with the prevalence, severity, and frequency of breast pain. This study showed a relationship between an increased prevalence of breast pain and a low level of physical activity. However, the severity of pain did not vary between either group. […] The prevalence of breast pain can vary depending on the region as well as ethnicity. Women in the United Kingdom report a 60% incidence of breast pain, while women of Asian ethnicity have been found to have a breast pain prevalence of 5%.
  • #10 Assessment of prevalence and factors affecting Mastalgia among early reproductive-aged women in Bangladesh: a cross-sectional survey | BMC Public Health | Full Text
    https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-17173-7
    Mastalgia, or breast pain, is a prevalent and distressing condition experienced by women, impacting their daily lives and causing complications. It is common among women of reproductive age, with associations found with premenstrual syndrome, fibrocystic breast disease, psychological distress, and, in rare cases, breast cancer. […] The prevalence of Mastalgia was found to be 35.5%. […] The study highlights the prevalence of mastalgia and its related factors, emphasizing the necessity for increased awareness and support for affected women. […] Up to two-thirds of women experience Mastalgia at some point during their reproductive years. […] In Western societies, Mastalgia, which refers to breast pain without any underlying pathology, is a common complaint that may affect up to 70% of women during their lifetime.
  • #11 Assessment of prevalence and factors affecting Mastalgia among early reproductive-aged women in Bangladesh: a cross-sectional survey | BMC Public Health | Full Text
    https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-17173-7
    In Bangladesh, a previous study reported that general breast pain was the second most prevalent breast-related complication, with an overall prevalence of 24.22%. […] The overall prevalence of Mastalgia was 35.5%. […] The findings suggest that public health interventions may be needed to reduce the burden of Mastalgia among certain populations, such as those with a family history of breast cancer or those with severe menstrual pain.
  • #12 Prevalence, Severity and Factors Related to Mastalgia among Women Referring to Health Centers Affiliated with Shiraz University of Medical Sciences
    https://jhsss.sums.ac.ir/article_42804.html
    Mastalgia is a common problem among women. Severe mastalgia can have a negative impact on sexual, physical and sleep activities and behaviors. […] The severity of breast pain was calculated with visual analog scale. […] Among 845 participants, 33% (279) of them had experienced mastalgia in the past three months. Among those who had experienced mastalgia, 81% (226) had cyclical mastalgia and 19% (53) had non-cyclical mastalgia. […] The impact of mastalgia on daily and sexual activities and sleep behaviors was reported 9.31% (26), 12.66% (29) and 13.97% (36), respectively. […] Results of this study showed that the spread of mastalgia in women referred to health centers affiliated to Shiraz University of Medical Sciences is lower than that reported in western studies and has lesser effects on their daily, sexual and sleep activities and behaviors.
  • #13 Prevalence, Severity and Factors Related to Mastalgia among Women Referring to Health Centers Affiliated with Shiraz University of Medical Sciences
    https://jhsss.sums.ac.ir/article_42804.html
    Mastalgia is a common problem among women. Severe mastalgia can have a negative impact on sexual, physical and sleep activities and behaviors. […] The severity of breast pain was calculated with visual analog scale. […] Among 845 participants, 33% (279) of them had experienced mastalgia in the past three months. Among those who had experienced mastalgia, 81% (226) had cyclical mastalgia and 19% (53) had non-cyclical mastalgia. […] The impact of mastalgia on daily and sexual activities and sleep behaviors was reported 9.31% (26), 12.66% (29) and 13.97% (36), respectively. […] Results of this study showed that the spread of mastalgia in women referred to health centers affiliated to Shiraz University of Medical Sciences is lower than that reported in western studies and has lesser effects on their daily, sexual and sleep activities and behaviors.
  • #14 Mastalgia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK562195/
    Mastalgia is uncommon in men but has been documented in male patients with conditions, eg, gynecomastia and hormonal dysfunction. […] The worldwide prevalence of breast pain varies depending on the population being studied. A study was conducted on women from the United Kingdom using a survey to correlate physical activity with the prevalence, severity, and frequency of breast pain. This study showed a relationship between an increased prevalence of breast pain and a low level of physical activity. However, the severity of pain did not vary between either group. […] The prevalence of breast pain can vary depending on the region as well as ethnicity. Women in the United Kingdom report a 60% incidence of breast pain, while women of Asian ethnicity have been found to have a breast pain prevalence of 5%.
  • #15 Mastalgia | 5-Minute Clinical Consult
    https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/1688714/all/Mastalgia
    Painful breast tissue, often bilateral, which can be cyclic or noncyclic. […] 2/3 of breast pain is cyclic and usually associated with hormonal changes related to menses, external hormones, pregnancy, or menopause. […] 1/3 is noncyclic and often is related to a breast or chest wall lesion. […] Predominant sex: most common in women but occurs occasionally in men. […] Predominant age: generally seen from adolescence to menopause. […] Frequency of breast cancer with those reporting breast pain ranges from 1.2% to 6.7%. […] Up to 70% of women report some degree of breast pain at some point in their lives. […] Most describe mild pain, but 11% describe pain as moderate to severe. […] Higher incidence in the older population, larger breasted individuals, and those who are less fit and active.
  • #16 Breast diseases: Detection, Management, and Surveillance of Breast Disease | Obgyn Key
    https://obgynkey.com/breast-diseases-detection-management-and-surveillance-of-breast-disease/
    The incidence of benign breast disorders begins to rise during the second decade of life and peaks in the fourth and fifth decades. […] More than two-thirds of women will experience breast pain at some time during their reproductive years, most commonly in the perimenopausal years. Approximately 90% of conditions that cause breast pain are benign. […] Breast pain is experienced by only 10% of women with early breast carcinoma. […] The classic sign of a breast carcinoma is a solitary, solid, three-dimensional, dominant breast mass. […] The correlation of a mass with malignancy is dependent on the patients age. The incidence of BBD begins to rise during the second decade of life and peaks in the fourth and fifth decades, as opposed to malignant diseases, whose incidence continues to increase after menopause.
  • #17 Common Breast Problems | AAFP
    https://www.aafp.org/pubs/afp/issues/2019/0415/p505.html
    Palpable breast masses, mastalgia, and nipple discharge are commonly encountered symptoms in outpatient practice, causing significant patient anxiety and precipitating medical consultation. […] Mastalgia is usually not an indication of underlying malignancy. […] Mastalgia is the second most common breast symptom leading to medical evaluation in the primary care setting. […] Although pain is often mild, up to 11% of women experience severe pain, and more than one-third of these patients report adverse effects on sleep and sexual activity. […] Cyclic mastalgia accounts for two-thirds of all breast pain cases and is most common in women in their 20s and 30s. […] Noncyclic mastalgia has no temporal association with menses and may be focal or diffuse. […] Noncyclic/focal mastalgia should trigger diagnostic imaging because of its rare but occasional association with underlying malignancy.
  • #18 Mastalgia | 5-Minute Clinical Consult
    https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/1688714/all/Mastalgia
    Painful breast tissue, often bilateral, which can be cyclic or noncyclic. […] 2/3 of breast pain is cyclic and usually associated with hormonal changes related to menses, external hormones, pregnancy, or menopause. […] 1/3 is noncyclic and often is related to a breast or chest wall lesion. […] Predominant sex: most common in women but occurs occasionally in men. […] Predominant age: generally seen from adolescence to menopause. […] Frequency of breast cancer with those reporting breast pain ranges from 1.2% to 6.7%. […] Up to 70% of women report some degree of breast pain at some point in their lives. […] Most describe mild pain, but 11% describe pain as moderate to severe. […] Higher incidence in the older population, larger breasted individuals, and those who are less fit and active.
  • #19
    https://fpnotebook.com/Gyn/Sx/Mstlg.htm
    Severe Breast Pain occurs in up to 11% of women […] Breast Pain thought to be related to Estrogen excess.
  • #20 Mastalgia | SpringerLink
    https://link.springer.com/chapter/10.1007/978-3-540-69743-5_4
    Mastalgia is a common breast symptom that may affect up to 70% of women in their lifetime. […] A proportion (10-20%) experience severe pain that causes distress, affects their daily lives and leads them to seek treatment. […] The severity of pain associated with cyclical mastalgia can be substantial, similar in magnitude to chronic cancer pain and slightly less than that associated with rheumatoid arthritis.
  • #21 Mastalgia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK562195/
    Mastalgia, or breast pain, affects up to 70% of women and is a frequent concern in primary care, though it is rarely linked to breast cancer. […] Experts estimate that 70% of women in the United States experience breast pain during their lifetime, of which around 30% seek medical attention. Of those patients who present to a clinician for evaluation of mastalgia, 20% have severe symptoms. […] The peak age of incidence for cyclic mastalgia is 20 to 30 years of life. The incidence decreases with increasing age and early pregnancy and is less commonly found in postmenopausal women. Noncyclic mastalgia has a higher prevalence in women aged between 30 and 40. […] Many female patients with breast pain report a negative impact on their life quality. Up to 40% of women will describe interference with sexual activity, interference with physical activity by 30%, and impact on work and social activities in 10% of patients.
  • #22 Prevalence, Severity and Factors Related to Mastalgia among Women Referring to Health Centers Affiliated with Shiraz University of Medical Sciences
    https://jhsss.sums.ac.ir/article_42804.html
    Mastalgia is a common problem among women. Severe mastalgia can have a negative impact on sexual, physical and sleep activities and behaviors. […] The severity of breast pain was calculated with visual analog scale. […] Among 845 participants, 33% (279) of them had experienced mastalgia in the past three months. Among those who had experienced mastalgia, 81% (226) had cyclical mastalgia and 19% (53) had non-cyclical mastalgia. […] The impact of mastalgia on daily and sexual activities and sleep behaviors was reported 9.31% (26), 12.66% (29) and 13.97% (36), respectively. […] Results of this study showed that the spread of mastalgia in women referred to health centers affiliated to Shiraz University of Medical Sciences is lower than that reported in western studies and has lesser effects on their daily, sexual and sleep activities and behaviors.
  • #23 Mastalgia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK562195/
    Mastalgia, or breast pain, affects up to 70% of women and is a frequent concern in primary care, though it is rarely linked to breast cancer. […] Experts estimate that 70% of women in the United States experience breast pain during their lifetime, of which around 30% seek medical attention. Of those patients who present to a clinician for evaluation of mastalgia, 20% have severe symptoms. […] The peak age of incidence for cyclic mastalgia is 20 to 30 years of life. The incidence decreases with increasing age and early pregnancy and is less commonly found in postmenopausal women. Noncyclic mastalgia has a higher prevalence in women aged between 30 and 40. […] Many female patients with breast pain report a negative impact on their life quality. Up to 40% of women will describe interference with sexual activity, interference with physical activity by 30%, and impact on work and social activities in 10% of patients.
  • #24 Breast Pain Treatment Melbourne, VIC | Mastalgia Treatment Melbourne, VIC
    https://www.melbournebreastcancersurgery.com.au/breast-painmastalgia.html
    Most breast complaints are benign in nature. […] Mastalgia affects up to 77% of women at some time in their lives, and is so common it is considered part of a normal bodily process rather than a disease. […] Doctors often think it a trivial symptom, but for many women mastalgia causes significant discomfort and anxiety. […] It should not be forgotten that mastalgia is a symptom, and therefore is not a specific disease in its own right. […] About 2 in 3 cases are cyclical breast pain, and about 1 in 3 are non-cyclical. […] Any woman with a breast symptom, including significant mastalgia, requires a full breast assessment including clinical breast examination and breast imaging to exclude cancer and other significant breast pathology as an explanation for the symptoms. […] Most women require no treatment at all simple reassurance is all that is needed.
  • #25 Pain and quality of life in breast cancer patients | Clinics
    https://www.elsevier.es/en-revista-clinics-22-articulo-pain-quality-life-in-breast-S1807593222011632
    Pain is one of the most frequently reported adverse effects that occurs as part of the disease process or as a side-effect of treatment. It is a problem for a majority of BC patients and has an unfavorable effect on QoL 1115. […] More recent epidemiological data obtained from a meta-analysis suggest that pain is prevalent in 39.3% of cases after curative treatment, 55.0% during cancer treatment, and in 66.4% in advanced or terminal stages of the disease 10. […] Pain compromises the quality of life of patients with breast cancer, particularly those with advanced stages of the disease. […] Despite cancer pain having been very prevalent in this study (71.7% of all groups), even in the non-metastatic group (56.8), the heterogeneity of sociodemographic and clinical characteristics of the subjects did not allow a specific statistical additional comparison between groups.
  • #26
    https://journals.lww.com/annals-of-medicine-and-surgery/fulltext/9900/clinicopathological_profile_of_mastalgia_in.927.aspx
    Mastalgia was the most common symptom in patients attending a breast clinic. The two most common types of mastalgia were (cyclical and non-cyclical). The aim of this study is to study the incidence of mastalgia, types (cyclical and non-cyclical) and pathological types of mastalgia (benign and malignant pathologies) […] Approximately 60-70% of women experience some degree of breast pain at some stage of their lives, 10-20% of these cases it is severe. The two most common concerns of patients presenting with mastalgia are the presence of severe pain, which affects quality of life and fear of breast cancer. Most patients with mastalgia can be treated with medication, as the pain is not connected to any severe problems; therefore, a vital responsibility of the breast specialist is to rule out cancer and assiduously reassure the patient.
  • #27 Breast pain: assessment, management, and referral criteria | British Journal of General Practice
    https://bjgp.org/content/70/697/419
    Breast pain (mastalgia) is experienced by 70% of women during their lifetime and may be considered a physiological symptom rather like painful menses, but remains a common presentation in primary care. […] Despite an absence of evidence suggesting that mastalgia alone is associated with breast cancer, it is still commonly referred to secondary care breast units in one study it accounted for 41% of referrals. […] Careful assessment is essential to avoid unnecessary referral, which can lead to anxiety or over-investigation. The National Institute for Health and Care Excellence (NICE) states that: breast pain is not a criteria for urgent referral, with a positive predictive value of 3% for breast cancer; and referral is recommended if cyclical breast pain is affecting quality of life or sleep, and has been ongoing for more than 3 months if the pain is unresponsive to first-line treatment. […] Breast pain can usually be safely managed in the primary care setting. Secondary care should support GPs and facilitate referral if suspected cancer referral criteria are met or where symptoms are not controlled with supportive measures or non-hormonal treatments.
  • #28 Breast Pain – Radiology | UCLA Health
    https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/how-work-up-patient-with/breast-pain
    Breast pain is an extremely common symptom experienced by 70-80% of women within their lifetimes. […] Unfortunately, it can significantly impact quality of life and provoke fear of underlying malignancy, often resulting in referral for diagnostic imaging. […] Fortunately, the causes of breast pain are typically benign and multiple studies have demonstrated a low association of pain with malignancy. […] In the absence of additional symptoms, isolated breast pain should be categorized as either clinically significant (focal and persistent pain involving 25% of the breast and axillary tissue) or clinically insignificant (cyclical/temporally associated with the menstrual cycle, non-focal/diffuse, and can be either unilateral or bilateral). […] As per the ACR Appropriateness Criteria for breast pain, imaging evaluation is usually appropriate for clinically significant pain to exclude an unlikely cancer as the cause of pain, to determine a treatable benign etiology, or to reassure the patient that there is no imaging abnormality present.
  • #29 Assessment of Breast Cancer Incidence in Patients with Mastalgia and Routine Screening
    https://clinmedjournals.org/articles/ijsrp/international-journal-of-surgery-research-and-practice-ijsrp-6-094.php?jid=ijsrp
    In this trial, we searched the incidence of breast cancer among the patients complained of breast pain and control group referred to our clinic. […] There was no increase in the incidence of cancer in patients presenting with breast pain. However, most patients with breast pain are exposed to imaging methods to exclude the cancer suspicion. […] The prevalence of cancer in patients manifesting with breast pain is reported to be 0-3.2% and in one study up to 7%. […] Even though studies support the view that no strong relations exist between breast pain and breast cancer, the uneasiness and fear of breast cancer caused by pain are persistent. […] In our study, breast cancer rate in patients with mastalgia (n = 646) was 0.8%. […] When we compare patients with mastalgia symptom and routine control, there is no difference in the incidence of breast cancer.
  • #30 Common Breast Problems | AAFP
    https://www.aafp.org/pubs/afp/issues/2019/0415/p505.html
    The risk of malignancy in patients with breast pain after normal CBE and mammography findings is approximately 0.5%. […] Although spontaneous resolution of breast pain is common, mastalgia can be chronic, necessitating a stepwise approach to management. […] Topical nonsteroidal anti-inflammatory drugs such as diclofenac are the first-line pharmacologic treatment for cyclic and noncyclic mastalgia. […] Diagnostic imaging is not needed in patients with cyclic mastalgia if routine screening mammography is up to date and physical examination findings are normal. […] The prevalence of cancer among women who report breast symptoms is estimated to be less than 10%, and those with breast lumps have a higher risk of malignancy than those with breast pain.
  • #31 Common Breast Problems | AAFP
    https://www.aafp.org/pubs/afp/issues/2019/0415/p505.html
    The risk of malignancy in patients with breast pain after normal CBE and mammography findings is approximately 0.5%. […] Although spontaneous resolution of breast pain is common, mastalgia can be chronic, necessitating a stepwise approach to management. […] Topical nonsteroidal anti-inflammatory drugs such as diclofenac are the first-line pharmacologic treatment for cyclic and noncyclic mastalgia. […] Diagnostic imaging is not needed in patients with cyclic mastalgia if routine screening mammography is up to date and physical examination findings are normal. […] The prevalence of cancer among women who report breast symptoms is estimated to be less than 10%, and those with breast lumps have a higher risk of malignancy than those with breast pain.
  • #32 Breast Pain – Radiology | UCLA Health
    https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/how-work-up-patient-with/breast-pain
    In cases where imaging is normal, some patients remain anxious and concerned about a potential for underlying malignancy, leading to repeated clinical and imaging follow-up. […] According to one study, there was 100% negative predictive value and 100% sensitivity for detecting malignancy in isolated pain with both mammography and ultrasound. […] In a review across multiple studies, the incidence of detecting malignancy in patients presenting with isolated clinically significant breast pain was 0.5%. […] Moreover, some studies have shown the incidence of detecting malignancy in those with breast pain was below the incidence in that of a general screening population. […] Thus, reassurance during the diagnostic consultation is important to help educate and minimize anxiety.
  • #33 Breast Pain – Radiology | UCLA Health
    https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/how-work-up-patient-with/breast-pain
    In cases where imaging is normal, some patients remain anxious and concerned about a potential for underlying malignancy, leading to repeated clinical and imaging follow-up. […] According to one study, there was 100% negative predictive value and 100% sensitivity for detecting malignancy in isolated pain with both mammography and ultrasound. […] In a review across multiple studies, the incidence of detecting malignancy in patients presenting with isolated clinically significant breast pain was 0.5%. […] Moreover, some studies have shown the incidence of detecting malignancy in those with breast pain was below the incidence in that of a general screening population. […] Thus, reassurance during the diagnostic consultation is important to help educate and minimize anxiety.
  • #34 No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic
    https://christie.openrepository.com/handle/10541/625289
    No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic. Women with breast pain constitute 20% of breast clinic attendees. Aim: To investigate breast cancer incidence in women presenting with breast pain and establish the health economics of referring women with breast pain to secondary care. Of 10 830 women, 1972 (18%) were referred with breast pain, 6708 (62%) with lumps, 480 (4%) with nipple symptoms, 1670 (15%) with 'other’ symptoms. Mammography, performed in 1112 women with breast pain, identified cancer in eight (0.7%). Of the 1972 women with breast pain, breast cancer incidence was 0.4% compared with 5% in each of the three other clinical groups. Using 'breast lump’ as reference, the odds ratio (OR) of women referred with breast pain having breast cancer was 0.05 (95% confidence interval = 0.02 to 0.09, P0.001). This study shows that referring women with breast pain to a breast diagnostic clinic is an inefficient use of limited resources. […] The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
  • #35 No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic | British Journal of General Practice
    https://bjgp.org/content/72/717/e234
    Women with breast pain constitute 20% of breast clinic attendees. […] This study shows that the incidence of breast cancer in women with breast pain alone (0.4%) is no higher than the background rate of cancer found in asymptomatic women undergoing breast screening (0.8%). […] Referring these women to a breast cancer diagnostic clinic is associated with no demonstrable health benefits but with increased costs and is not an effective use of healthcare resources. […] Women with breast pain should be reassured that they are at no greater risk of breast cancer than asymptomatic women. […] The incidence of pre-invasive or invasive malignancy in women referred with breast pain alone was 0.4%, compared with 5.4% incidence seen in women referred with a breast lump. […] On multivariable logistic regression modelling women referred with breast pain alone were 20 times less likely to have breast cancer compared with those with breast lumps, after adjustment for age (OR 0.05, 95% CI = 0.02 to 0.09; P0.001).
  • #36 Assessment of Breast Cancer Incidence in Patients with Mastalgia and Routine Screening
    https://clinmedjournals.org/articles/ijsrp/international-journal-of-surgery-research-and-practice-ijsrp-6-094.php?jid=ijsrp
    In this trial, we searched the incidence of breast cancer among the patients complained of breast pain and control group referred to our clinic. […] There was no increase in the incidence of cancer in patients presenting with breast pain. However, most patients with breast pain are exposed to imaging methods to exclude the cancer suspicion. […] The prevalence of cancer in patients manifesting with breast pain is reported to be 0-3.2% and in one study up to 7%. […] Even though studies support the view that no strong relations exist between breast pain and breast cancer, the uneasiness and fear of breast cancer caused by pain are persistent. […] In our study, breast cancer rate in patients with mastalgia (n = 646) was 0.8%. […] When we compare patients with mastalgia symptom and routine control, there is no difference in the incidence of breast cancer.
  • #37 Assessment of Breast Cancer Incidence in Patients with Mastalgia and Routine Screening
    https://clinmedjournals.org/articles/ijsrp/international-journal-of-surgery-research-and-practice-ijsrp-6-094.php?jid=ijsrp
    In this trial, we searched the incidence of breast cancer among the patients complained of breast pain and control group referred to our clinic. […] There was no increase in the incidence of cancer in patients presenting with breast pain. However, most patients with breast pain are exposed to imaging methods to exclude the cancer suspicion. […] The prevalence of cancer in patients manifesting with breast pain is reported to be 0-3.2% and in one study up to 7%. […] Even though studies support the view that no strong relations exist between breast pain and breast cancer, the uneasiness and fear of breast cancer caused by pain are persistent. […] In our study, breast cancer rate in patients with mastalgia (n = 646) was 0.8%. […] When we compare patients with mastalgia symptom and routine control, there is no difference in the incidence of breast cancer.
  • #38 Is Breast Pain an Indicator of Breast Cancer? – The ObG Project
    https://www.obgproject.com/2018/09/13/is-breast-pain-an-indicator-of-breast-cancer/
    Breast pain may be a symptom of breast cancer. However, radiographic studies have indicated only a 0-1.2% incidence of breast cancer in association with breast pain. US Data regarding the cancer incidence of patients entering a breast imaging center for evaluation of breast pain is not available. Kushwaha et al. (American Journal of Roentgenology, 2018) analyzed the incidence of breast pain, and the incidence of breast cancer in women with breast pain, and compared these data who women who present as part of the general screening population. […] Breast pain was not helpful as a screening symptom/indication for breast cancer and consequent breast cancer screening cost significant money for imaging centers. The authors recommend the following work-up for breast pain alone (no mass) “should include an annual screening mammogram for women 40 years or older and reassurance for female patients younger than 40 years.”
  • #39 Breast Pain – Radiology | UCLA Health
    https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/how-work-up-patient-with/breast-pain
    In cases where imaging is normal, some patients remain anxious and concerned about a potential for underlying malignancy, leading to repeated clinical and imaging follow-up. […] According to one study, there was 100% negative predictive value and 100% sensitivity for detecting malignancy in isolated pain with both mammography and ultrasound. […] In a review across multiple studies, the incidence of detecting malignancy in patients presenting with isolated clinically significant breast pain was 0.5%. […] Moreover, some studies have shown the incidence of detecting malignancy in those with breast pain was below the incidence in that of a general screening population. […] Thus, reassurance during the diagnostic consultation is important to help educate and minimize anxiety.
  • #40 Common Breast Problems | AAFP
    https://www.aafp.org/pubs/afp/issues/2019/0415/p505.html
    Palpable breast masses, mastalgia, and nipple discharge are commonly encountered symptoms in outpatient practice, causing significant patient anxiety and precipitating medical consultation. […] Mastalgia is usually not an indication of underlying malignancy. […] Mastalgia is the second most common breast symptom leading to medical evaluation in the primary care setting. […] Although pain is often mild, up to 11% of women experience severe pain, and more than one-third of these patients report adverse effects on sleep and sexual activity. […] Cyclic mastalgia accounts for two-thirds of all breast pain cases and is most common in women in their 20s and 30s. […] Noncyclic mastalgia has no temporal association with menses and may be focal or diffuse. […] Noncyclic/focal mastalgia should trigger diagnostic imaging because of its rare but occasional association with underlying malignancy.
  • #41 Breast Pain Treatment Melbourne, VIC | Mastalgia Treatment Melbourne, VIC
    https://www.melbournebreastcancersurgery.com.au/breast-painmastalgia.html
    Most breast complaints are benign in nature. […] Mastalgia affects up to 77% of women at some time in their lives, and is so common it is considered part of a normal bodily process rather than a disease. […] Doctors often think it a trivial symptom, but for many women mastalgia causes significant discomfort and anxiety. […] It should not be forgotten that mastalgia is a symptom, and therefore is not a specific disease in its own right. […] About 2 in 3 cases are cyclical breast pain, and about 1 in 3 are non-cyclical. […] Any woman with a breast symptom, including significant mastalgia, requires a full breast assessment including clinical breast examination and breast imaging to exclude cancer and other significant breast pathology as an explanation for the symptoms. […] Most women require no treatment at all simple reassurance is all that is needed.
  • #42 Common Breast Problems | AAFP
    https://www.aafp.org/pubs/afp/issues/2019/0415/p505.html
    Palpable breast masses, mastalgia, and nipple discharge are commonly encountered symptoms in outpatient practice, causing significant patient anxiety and precipitating medical consultation. […] Mastalgia is usually not an indication of underlying malignancy. […] Mastalgia is the second most common breast symptom leading to medical evaluation in the primary care setting. […] Although pain is often mild, up to 11% of women experience severe pain, and more than one-third of these patients report adverse effects on sleep and sexual activity. […] Cyclic mastalgia accounts for two-thirds of all breast pain cases and is most common in women in their 20s and 30s. […] Noncyclic mastalgia has no temporal association with menses and may be focal or diffuse. […] Noncyclic/focal mastalgia should trigger diagnostic imaging because of its rare but occasional association with underlying malignancy.
  • #43 Common Breast Problems | AAFP
    https://www.aafp.org/pubs/afp/issues/2019/0415/p505.html
    Palpable breast masses, mastalgia, and nipple discharge are commonly encountered symptoms in outpatient practice, causing significant patient anxiety and precipitating medical consultation. […] Mastalgia is usually not an indication of underlying malignancy. […] Mastalgia is the second most common breast symptom leading to medical evaluation in the primary care setting. […] Although pain is often mild, up to 11% of women experience severe pain, and more than one-third of these patients report adverse effects on sleep and sexual activity. […] Cyclic mastalgia accounts for two-thirds of all breast pain cases and is most common in women in their 20s and 30s. […] Noncyclic mastalgia has no temporal association with menses and may be focal or diffuse. […] Noncyclic/focal mastalgia should trigger diagnostic imaging because of its rare but occasional association with underlying malignancy.
  • #44 Assessment of Breast Cancer Incidence in Patients with Mastalgia and Routine Screening
    https://clinmedjournals.org/articles/ijsrp/international-journal-of-surgery-research-and-practice-ijsrp-6-094.php?jid=ijsrp
    Breast cancer risk was not increased in women presenting with breast pain. […] Most patients with breast pain are exposed to imaging methods to exclude the cancer suspicion. However, breast imaging for any type of breast pain can help determine if there is a underlying and curable cause. […] Since all patients with cancer in the mastalgia group are non-cyclic and most of them are postmenopausal, we have to conclude that patients with this characteristic should be investigated better.
  • #45 Common Breast Problems | AAFP
    https://www.aafp.org/pubs/afp/issues/2019/0415/p505.html
    The risk of malignancy in patients with breast pain after normal CBE and mammography findings is approximately 0.5%. […] Although spontaneous resolution of breast pain is common, mastalgia can be chronic, necessitating a stepwise approach to management. […] Topical nonsteroidal anti-inflammatory drugs such as diclofenac are the first-line pharmacologic treatment for cyclic and noncyclic mastalgia. […] Diagnostic imaging is not needed in patients with cyclic mastalgia if routine screening mammography is up to date and physical examination findings are normal. […] The prevalence of cancer among women who report breast symptoms is estimated to be less than 10%, and those with breast lumps have a higher risk of malignancy than those with breast pain.
  • #46 Assessment of Breast Cancer Incidence in Patients with Mastalgia and Routine Screening
    https://clinmedjournals.org/articles/ijsrp/international-journal-of-surgery-research-and-practice-ijsrp-6-094.php?jid=ijsrp
    Breast cancer risk was not increased in women presenting with breast pain. […] Most patients with breast pain are exposed to imaging methods to exclude the cancer suspicion. However, breast imaging for any type of breast pain can help determine if there is a underlying and curable cause. […] Since all patients with cancer in the mastalgia group are non-cyclic and most of them are postmenopausal, we have to conclude that patients with this characteristic should be investigated better.
  • #47 Breast Pain – Radiology | UCLA Health
    https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/how-work-up-patient-with/breast-pain
    Breast pain is an extremely common symptom experienced by 70-80% of women within their lifetimes. […] Unfortunately, it can significantly impact quality of life and provoke fear of underlying malignancy, often resulting in referral for diagnostic imaging. […] Fortunately, the causes of breast pain are typically benign and multiple studies have demonstrated a low association of pain with malignancy. […] In the absence of additional symptoms, isolated breast pain should be categorized as either clinically significant (focal and persistent pain involving 25% of the breast and axillary tissue) or clinically insignificant (cyclical/temporally associated with the menstrual cycle, non-focal/diffuse, and can be either unilateral or bilateral). […] As per the ACR Appropriateness Criteria for breast pain, imaging evaluation is usually appropriate for clinically significant pain to exclude an unlikely cancer as the cause of pain, to determine a treatable benign etiology, or to reassure the patient that there is no imaging abnormality present.
  • #48 The Evaluation of Common Breast Problems | AAFP
    https://www.aafp.org/pubs/afp/issues/2000/0415/p2371.html
    Breast pain is the most common breast symptom causing women to consult primary care physicians and surgeons. Mastalgia is more common in pre-menopausal women than in postmenopausal women, and it is rarely a presenting symptom of breast cancer. […] The evaluation of breast pain begins with a thorough history and a careful physical examination. Special attention should be given to the type of pain, its location and its relationship to the menstrual cycle. […] In the vast majority of women with breast pain, the physical examination and mammography reveal no evidence of breast pathology. […] Breast pain should be treated when it is severe enough to interfere with a woman’s lifestyle and occurs for more than a few days each month. […] Because of the extreme variability in breast pain, only treatments that have been tested in randomized, controlled trials can confidently be considered beneficial. […] Surgery has no role in the management of breast pain in the absence of a dominant mass.
  • #49 The Evaluation of Common Breast Problems | AAFP
    https://www.aafp.org/pubs/afp/issues/2000/0415/p2371.html
    Breast pain is the most common breast symptom causing women to consult primary care physicians and surgeons. Mastalgia is more common in pre-menopausal women than in postmenopausal women, and it is rarely a presenting symptom of breast cancer. […] The evaluation of breast pain begins with a thorough history and a careful physical examination. Special attention should be given to the type of pain, its location and its relationship to the menstrual cycle. […] In the vast majority of women with breast pain, the physical examination and mammography reveal no evidence of breast pathology. […] Breast pain should be treated when it is severe enough to interfere with a woman’s lifestyle and occurs for more than a few days each month. […] Because of the extreme variability in breast pain, only treatments that have been tested in randomized, controlled trials can confidently be considered beneficial. […] Surgery has no role in the management of breast pain in the absence of a dominant mass.
  • #50 Breast pain: An evidence-based case report – Women’s Healthcare
    https://www.npwomenshealthcare.com/breast-pain-evidence-based-case-report/
    The NP reassures SM that breast pain in women is common, especially in the fourth and fifth decades of life. Reassurance is first-line treatment for mastalgia and can be effective for as many as 85% of women, with greater success achieved in patients with mild or moderate cases than in those with severe mastalgia. […] Fibroadenomas are the most common benign tumors in the breast, and appear most commonly in females in their teens, 20s, or 30s. They are solid masses of both glandular breast tissue and stromal (connective) tissue. They are not precancerous and are not excised unless they grow quickly or are extremely painful. […] A prospective breast pain diary may be helpful if the NP is trying to differentiate cyclic mastalgia from noncyclic mastalgia. […] A study showed that diclofenac gel, a topical NSAID applied to painful areas of the breast 3 times daily for 6 months, was superior to placebo in effectuating relief of both cyclic and noncyclic mastalgia, with no side effects. […] For patients with more severe debilitation from mastalgia, pharmacotherapies such as danazol, tamoxifen, or bromocriptine may be considered. A meta-analysis of randomized trials found that all three of these medications offer significant relief from mastalgia.
  • #51 Breast diseases: Detection, Management, and Surveillance of Breast Disease | Obgyn Key
    https://obgynkey.com/breast-diseases-detection-management-and-surveillance-of-breast-disease/
    More than two-thirds of women will experience breast pain at some time during their reproductive years, most commonly in the perimenopausal years. […] Approximately 90% of conditions that cause breast pain are benign. […] Breast pain is typically divided into cyclic pain, related to the menstrual cycle, and noncyclic pain. […] Noncyclic breast pain should be evaluated, particularly in older women, because there is a small association with malignancy. […] Pain as a presenting symptom of malignancy is uncommon in general and is extremely rare in the absence of mass or skin changes. […] Breast pain treatment is directed at the cause; however, nonsteroidal antiinflammatories are often useful when pain is idiopathic.
  • #52 No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic | British Journal of General Practice
    https://bjgp.org/content/72/717/e234
    Women with breast pain constitute 20% of breast clinic attendees. […] This study shows that the incidence of breast cancer in women with breast pain alone (0.4%) is no higher than the background rate of cancer found in asymptomatic women undergoing breast screening (0.8%). […] Referring these women to a breast cancer diagnostic clinic is associated with no demonstrable health benefits but with increased costs and is not an effective use of healthcare resources. […] Women with breast pain should be reassured that they are at no greater risk of breast cancer than asymptomatic women. […] The incidence of pre-invasive or invasive malignancy in women referred with breast pain alone was 0.4%, compared with 5.4% incidence seen in women referred with a breast lump. […] On multivariable logistic regression modelling women referred with breast pain alone were 20 times less likely to have breast cancer compared with those with breast lumps, after adjustment for age (OR 0.05, 95% CI = 0.02 to 0.09; P0.001).
  • #53 No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic | British Journal of General Practice
    https://bjgp.org/content/72/717/e234
    The total cost of breast clinic attendances for the 1972 women referred with pain alone was 531 817, thus the cost per case of breast cancer identified in this group (n = 8) was 66 477. […] The greatest impact on the ICER was when any QALY loss because of anxiety associated with being referred was excluded; primary care reassurance no longer dominated, but the ICER (45 528/QALY) was still greater than typical cost-effectiveness thresholds used in decision making in the UK NHS.
  • #54 No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic | British Journal of General Practice
    https://bjgp.org/content/72/717/e234
    The total cost of breast clinic attendances for the 1972 women referred with pain alone was 531 817, thus the cost per case of breast cancer identified in this group (n = 8) was 66 477. […] The greatest impact on the ICER was when any QALY loss because of anxiety associated with being referred was excluded; primary care reassurance no longer dominated, but the ICER (45 528/QALY) was still greater than typical cost-effectiveness thresholds used in decision making in the UK NHS.
  • #55 Predictors of postoperative pain six months after breast surgery | Scientific Reports
    https://www.nature.com/articles/s41598-023-35426-8
    Breast cancer, with a high prevalence and survival rate, leads to long-term complications. A major sequel is acute or chronic postoperative pain, and we investigated the possible relationship with clinical and psychological variables. […] Acute and chronic pain are among the most common complications of surgery. Postoperative pain impairs physical, psychological, and social function and reduces the quality of life. […] Various characteristics have been investigated as potential risk factors, including loneliness; and is defined as experiencing psychological distress due to a feeling of inadequate social relationships. […] A significant positive correlation was found between the ULS-8 score and pain on the second and sixth postoperative days, along with the sixth-month pain. […] Results showed that a one-unit increase in preoperative pain was associated with a 0.22 increase in second-day pain (p-value=0.044) and a 0.2 increase in the sixth-month pain (p-value=0.026). Increase in ULS-8 was significantly related to higher pain values on the second day (b=0.13, p-value=0.011), on the seventh day (b=0.09, p-value=0.019), and on the sixth month (b=0.014, p-value=0.001). And the self-reported loneliness was associated with higher pain in the sixth month (b=0.51, p-value=0.003).
  • #56 Predictors of postoperative pain six months after breast surgery | Scientific Reports
    https://www.nature.com/articles/s41598-023-35426-8
    Breast cancer, with a high prevalence and survival rate, leads to long-term complications. A major sequel is acute or chronic postoperative pain, and we investigated the possible relationship with clinical and psychological variables. […] Acute and chronic pain are among the most common complications of surgery. Postoperative pain impairs physical, psychological, and social function and reduces the quality of life. […] Various characteristics have been investigated as potential risk factors, including loneliness; and is defined as experiencing psychological distress due to a feeling of inadequate social relationships. […] A significant positive correlation was found between the ULS-8 score and pain on the second and sixth postoperative days, along with the sixth-month pain. […] Results showed that a one-unit increase in preoperative pain was associated with a 0.22 increase in second-day pain (p-value=0.044) and a 0.2 increase in the sixth-month pain (p-value=0.026). Increase in ULS-8 was significantly related to higher pain values on the second day (b=0.13, p-value=0.011), on the seventh day (b=0.09, p-value=0.019), and on the sixth month (b=0.014, p-value=0.001). And the self-reported loneliness was associated with higher pain in the sixth month (b=0.51, p-value=0.003).
  • #57 Predictors of postoperative pain six months after breast surgery | Scientific Reports
    https://www.nature.com/articles/s41598-023-35426-8
    Preoperative pain (p-value=0.007), self-reported loneliness (p-value=0.01), and adjuvant radiotherapy (p-value=0.004) had significant effects on sixth-month pain. […] We found that six months after breast surgery, 47.6% of patients still experienced clinically meaningful pain, of which 8.9% had severe pain. […] The prevalence of chronic postoperative pain in breast surgery ranges from 25 to 60%, based on the study population and variations in defining persistent pain. […] We also found a significant correlation between acute and chronic postoperative pain intensity, in line with previous works. […] In our study, the feeling of loneliness was significantly associated with acute and chronic pain intensity. […] Our findings suggest that clinicians should give more attention to patients’ psychological distress to minimize physical complications, and further studies with larger cohorts and wider scopes should be designed.
  • #58 Predictors of postoperative pain six months after breast surgery | Scientific Reports
    https://www.nature.com/articles/s41598-023-35426-8
    Preoperative pain (p-value=0.007), self-reported loneliness (p-value=0.01), and adjuvant radiotherapy (p-value=0.004) had significant effects on sixth-month pain. […] We found that six months after breast surgery, 47.6% of patients still experienced clinically meaningful pain, of which 8.9% had severe pain. […] The prevalence of chronic postoperative pain in breast surgery ranges from 25 to 60%, based on the study population and variations in defining persistent pain. […] We also found a significant correlation between acute and chronic postoperative pain intensity, in line with previous works. […] In our study, the feeling of loneliness was significantly associated with acute and chronic pain intensity. […] Our findings suggest that clinicians should give more attention to patients’ psychological distress to minimize physical complications, and further studies with larger cohorts and wider scopes should be designed.
  • #59
    https://www.resed.es/incidence-of-postmastectomy-pain-syndrome-retrospective-analysis997
    ABSTRACT Introduction: The posmastectomy pain syndrome (PMPS) is included in the new ICD-11 (International Classification of Diseases 11th Revision) classification under the postsurgical pain syndrome subset. […] The published incidence of PMPS varies between 11-57 % according to different sources. […] The incidence lowers to 5-10 % when the pain is judged severe. […] Up to the 65 % of the patients present neuropathic characteristics. […] The aim of this article is to primary to determine the frequency and intensity of the incidence of, and seconddly to elucidate possible risk factors to influence its appearance. […] No relationship was found between the appearance of chronic pain and any of the variables studied. […] We judge necessary to perform new prospective studies which include a consensuated definition of PMPS to clearly elucidate possible risk factors that can contribute either to the incidence, intensity or impact in quality of life of our patients.
  • #60
    https://www.resed.es/incidence-of-postmastectomy-pain-syndrome-retrospective-analysis997
    ABSTRACT Introduction: The posmastectomy pain syndrome (PMPS) is included in the new ICD-11 (International Classification of Diseases 11th Revision) classification under the postsurgical pain syndrome subset. […] The published incidence of PMPS varies between 11-57 % according to different sources. […] The incidence lowers to 5-10 % when the pain is judged severe. […] Up to the 65 % of the patients present neuropathic characteristics. […] The aim of this article is to primary to determine the frequency and intensity of the incidence of, and seconddly to elucidate possible risk factors to influence its appearance. […] No relationship was found between the appearance of chronic pain and any of the variables studied. […] We judge necessary to perform new prospective studies which include a consensuated definition of PMPS to clearly elucidate possible risk factors that can contribute either to the incidence, intensity or impact in quality of life of our patients.
  • #61
    https://www.resed.es/incidence-of-postmastectomy-pain-syndrome-retrospective-analysis997
    La incidencia documentada de SDPM vara segn las publicaciones entre un 11 y un 57 %, bajando a un 5-10 % en caso de que sea severo, destacando que hasta el 65 % de los casos presentan caractersticas neuropticas. […] El objetivo primario de este trabajo es determinar la frecuencia y la intensidad de la incidencia del SDPM y el secundario identificar posibles factores de riesgo para su desarrollo. […] No hubo relacin entre el riesgo de dolor crnico y cualquiera de las variables analizadas. […] En nuestra opinin, parece necesario realizar nuevos estudios prospectivos que incluyan una definicin consensuada del SDPM para evaluar los posibles factores de riesgo que afecten tanto en incidencia, intensidad e impacto en la calidad de vida de nuestros pacientes.
  • #62
    https://www.resed.es/incidence-of-postmastectomy-pain-syndrome-retrospective-analysis997
    ABSTRACT Introduction: The posmastectomy pain syndrome (PMPS) is included in the new ICD-11 (International Classification of Diseases 11th Revision) classification under the postsurgical pain syndrome subset. […] The published incidence of PMPS varies between 11-57 % according to different sources. […] The incidence lowers to 5-10 % when the pain is judged severe. […] Up to the 65 % of the patients present neuropathic characteristics. […] The aim of this article is to primary to determine the frequency and intensity of the incidence of, and seconddly to elucidate possible risk factors to influence its appearance. […] No relationship was found between the appearance of chronic pain and any of the variables studied. […] We judge necessary to perform new prospective studies which include a consensuated definition of PMPS to clearly elucidate possible risk factors that can contribute either to the incidence, intensity or impact in quality of life of our patients.
  • #63 Breast pain: An evidence-based case report – Women’s Healthcare
    https://www.npwomenshealthcare.com/breast-pain-evidence-based-case-report/
    The NP reassures SM that breast pain in women is common, especially in the fourth and fifth decades of life. Reassurance is first-line treatment for mastalgia and can be effective for as many as 85% of women, with greater success achieved in patients with mild or moderate cases than in those with severe mastalgia. […] Fibroadenomas are the most common benign tumors in the breast, and appear most commonly in females in their teens, 20s, or 30s. They are solid masses of both glandular breast tissue and stromal (connective) tissue. They are not precancerous and are not excised unless they grow quickly or are extremely painful. […] A prospective breast pain diary may be helpful if the NP is trying to differentiate cyclic mastalgia from noncyclic mastalgia. […] A study showed that diclofenac gel, a topical NSAID applied to painful areas of the breast 3 times daily for 6 months, was superior to placebo in effectuating relief of both cyclic and noncyclic mastalgia, with no side effects. […] For patients with more severe debilitation from mastalgia, pharmacotherapies such as danazol, tamoxifen, or bromocriptine may be considered. A meta-analysis of randomized trials found that all three of these medications offer significant relief from mastalgia.
  • #64 Breast Pain – Radiology | UCLA Health
    https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/how-work-up-patient-with/breast-pain
    In cases where imaging is normal, some patients remain anxious and concerned about a potential for underlying malignancy, leading to repeated clinical and imaging follow-up. […] According to one study, there was 100% negative predictive value and 100% sensitivity for detecting malignancy in isolated pain with both mammography and ultrasound. […] In a review across multiple studies, the incidence of detecting malignancy in patients presenting with isolated clinically significant breast pain was 0.5%. […] Moreover, some studies have shown the incidence of detecting malignancy in those with breast pain was below the incidence in that of a general screening population. […] Thus, reassurance during the diagnostic consultation is important to help educate and minimize anxiety.
  • #65 Breast Pain – Radiology | UCLA Health
    https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/how-work-up-patient-with/breast-pain
    In cases where imaging is normal, some patients remain anxious and concerned about a potential for underlying malignancy, leading to repeated clinical and imaging follow-up. […] According to one study, there was 100% negative predictive value and 100% sensitivity for detecting malignancy in isolated pain with both mammography and ultrasound. […] In a review across multiple studies, the incidence of detecting malignancy in patients presenting with isolated clinically significant breast pain was 0.5%. […] Moreover, some studies have shown the incidence of detecting malignancy in those with breast pain was below the incidence in that of a general screening population. […] Thus, reassurance during the diagnostic consultation is important to help educate and minimize anxiety.
  • #66 Breast Pain – Radiology | UCLA Health
    https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/how-work-up-patient-with/breast-pain
    Breast pain is an extremely common symptom experienced by 70-80% of women within their lifetimes. […] Unfortunately, it can significantly impact quality of life and provoke fear of underlying malignancy, often resulting in referral for diagnostic imaging. […] Fortunately, the causes of breast pain are typically benign and multiple studies have demonstrated a low association of pain with malignancy. […] In the absence of additional symptoms, isolated breast pain should be categorized as either clinically significant (focal and persistent pain involving 25% of the breast and axillary tissue) or clinically insignificant (cyclical/temporally associated with the menstrual cycle, non-focal/diffuse, and can be either unilateral or bilateral). […] As per the ACR Appropriateness Criteria for breast pain, imaging evaluation is usually appropriate for clinically significant pain to exclude an unlikely cancer as the cause of pain, to determine a treatable benign etiology, or to reassure the patient that there is no imaging abnormality present.
  • #67 Assessment of prevalence and factors affecting Mastalgia among early reproductive-aged women in Bangladesh: a cross-sectional survey | BMC Public Health | Full Text
    https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-17173-7
    Mastalgia, or breast pain, is a prevalent and distressing condition experienced by women, impacting their daily lives and causing complications. It is common among women of reproductive age, with associations found with premenstrual syndrome, fibrocystic breast disease, psychological distress, and, in rare cases, breast cancer. […] The prevalence of Mastalgia was found to be 35.5%. […] The study highlights the prevalence of mastalgia and its related factors, emphasizing the necessity for increased awareness and support for affected women. […] Up to two-thirds of women experience Mastalgia at some point during their reproductive years. […] In Western societies, Mastalgia, which refers to breast pain without any underlying pathology, is a common complaint that may affect up to 70% of women during their lifetime.
  • #68 Breast Pain Treatment Melbourne, VIC | Mastalgia Treatment Melbourne, VIC
    https://www.melbournebreastcancersurgery.com.au/breast-painmastalgia.html
    Studies have shown that cyclical breast pain goes away within three months of onset in about 3 in 10 cases. […] The simplest and perhaps most commonly used first line treatment for mastalgia is Evening Primrose Oil, which proves helpful for many women. […] Simple pain medication such as paracetamol can reduce mastalgia. […] Research has shown that non-steroidal anti-inflammatory pain relief, such as ibuprofen, can help breast pain, particularly non-cyclical pain. […] For severe cases of mastalgia that interfere with lifestyle, there are strong hormonal medications such as tamoxifen, danazol and bromocryptine.
  • #69 Breast pain – Wikipedia
    https://en.wikipedia.org/wiki/Breast_pain
    Breast pain is one of the most common breast symptoms, along with breast masses and nipple discharge. […] About 70% of women have breast pain at some point in time. […] In more than 75% of people the pain resolves without any specific treatment. […] Diagnosis involves breast examination, with medical imaging if only a specific part of the breast hurts. […] Diagnostic testing can be useful. Typical tests used are mammogram, excisional biopsy for solid lumps, fine-needle aspiration and biopsy, pregnancy test, ultrasonography, and magnetic resonance imaging (MRI). […] Ruling out the other possible causes of the pain is one way to differentiate the source of the pain.
  • #70 No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic | British Journal of General Practice
    https://bjgp.org/content/72/717/e234
    Women with breast pain constitute 20% of breast clinic attendees. […] This study shows that the incidence of breast cancer in women with breast pain alone (0.4%) is no higher than the background rate of cancer found in asymptomatic women undergoing breast screening (0.8%). […] Referring these women to a breast cancer diagnostic clinic is associated with no demonstrable health benefits but with increased costs and is not an effective use of healthcare resources. […] Women with breast pain should be reassured that they are at no greater risk of breast cancer than asymptomatic women. […] The incidence of pre-invasive or invasive malignancy in women referred with breast pain alone was 0.4%, compared with 5.4% incidence seen in women referred with a breast lump. […] On multivariable logistic regression modelling women referred with breast pain alone were 20 times less likely to have breast cancer compared with those with breast lumps, after adjustment for age (OR 0.05, 95% CI = 0.02 to 0.09; P0.001).
  • #71 No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic | British Journal of General Practice
    https://bjgp.org/content/72/717/e234
    Women with breast pain constitute 20% of breast clinic attendees. […] This study shows that the incidence of breast cancer in women with breast pain alone (0.4%) is no higher than the background rate of cancer found in asymptomatic women undergoing breast screening (0.8%). […] Referring these women to a breast cancer diagnostic clinic is associated with no demonstrable health benefits but with increased costs and is not an effective use of healthcare resources. […] Women with breast pain should be reassured that they are at no greater risk of breast cancer than asymptomatic women. […] The incidence of pre-invasive or invasive malignancy in women referred with breast pain alone was 0.4%, compared with 5.4% incidence seen in women referred with a breast lump. […] On multivariable logistic regression modelling women referred with breast pain alone were 20 times less likely to have breast cancer compared with those with breast lumps, after adjustment for age (OR 0.05, 95% CI = 0.02 to 0.09; P0.001).
  • #72 The prevalence, severity, and impact of breast pain in the general population – PubMed
    https://pubmed.ncbi.nlm.nih.gov/25041468/
    Breast pain has been investigated in clinical populations; however we have yet to understand the prevalence and severity of this condition in the general population to determine whether more should be done to minimize the impact of this condition on women’s quality of life. […] Therefore, this study investigated the prevalence, severity, and impact of breast pain on quality of life and factors associated with breast pain in a normal population sample. […] Over half the sample (51.5%) experienced breast pain, with a severity similar to that reported in clinical populations. […] The results of this study suggest that breast pain is a significant issue within the general population and yet this is the first study to investigate it. […] It is concluded that this condition warrants increased investigation, awareness, and treatment.
  • #73 The prevalence, severity, and impact of breast pain in the general population – PubMed
    https://pubmed.ncbi.nlm.nih.gov/25041468/
    Breast pain has been investigated in clinical populations; however we have yet to understand the prevalence and severity of this condition in the general population to determine whether more should be done to minimize the impact of this condition on women’s quality of life. […] Therefore, this study investigated the prevalence, severity, and impact of breast pain on quality of life and factors associated with breast pain in a normal population sample. […] Over half the sample (51.5%) experienced breast pain, with a severity similar to that reported in clinical populations. […] The results of this study suggest that breast pain is a significant issue within the general population and yet this is the first study to investigate it. […] It is concluded that this condition warrants increased investigation, awareness, and treatment.